Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics of controlled ovarian hyperstimulation.

Pharmacogenomics - 1 Sept 2005

de Castro Francisco, Morón Francisco J, Montoro Luis, Real Luis M, Ruiz Agustín

Abstract excerpt

Controlled ovarian hyperstimulation (COH) is a routine treatment employed in most assisted reproductive techniques (ARTs). The existence of genetic factors involved in COH has been suspected. The main challenge for clinicians involved in ART is COH cycle cancellation, which usually occurs due to two opposing situations. On the one hand, there is the presence of a poor response during COH treatment, and on the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Estrogens
Share to Follicle Stimulating Hormone
Share to Gonadotropin-Releasing Hormone

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Ovulation Induction

Share to Pharmacogenetics

Share to Pregnancy

Share to Receptors, FSH

Source

Identifiers

PMID: 16143002
DOI: 10.2217/14622416.6.6.629

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics of controlled ovarian hyperstimulation.PMID 16143002Read ↗

Pharmacogenetic algorithm for individualized controlled ovarian stimulation in assisted reproductive technology cycles.Semantic proximity Read ↗

Pharmacogenetics of controlled ovarian hyperstimulation: time to corroborate the clinical utility of FSH receptor genetic markers.Semantic proximity Read ↗

Pharmacogenetics of ovarian response.Semantic proximity Read ↗

Clinical relevance of genetic variants of gonadotrophins and their receptors in controlled ovarian stimulation: a systematic review and meta-analysis.Semantic proximity Read ↗

Pharmacogenomics in IVF: A New Era in the Concept of Personalized Medicine.Semantic proximity Read ↗

Genetic profile of SNP(s) and ovulation induction.Semantic proximity Read ↗

Pharmacogenetics of FSH Action in the FemaleSemantic proximity Read ↗

Genetic predictors of controlled ovarian hyperstimulation: where do we stand today?Semantic proximity Read ↗

A pharmacogenetic-driven approach for controlled ovarian hyperstimulation by FSH treatment.Semantic proximity Read ↗

Controlled ovarian hyperstimulation pharmacogenetics: a simplified model to genetically dissect estrogen-related diseases.Semantic proximity Read ↗

Pharmacogenomic of LH and its receptor: are we ready for clinical practice?Semantic proximity Read ↗

Impact of gonadotropin genetic profile and ovarian reserve on controlled ovarian stimulation: data from prospective cohort of the GENACOS trialSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.